REGISTERED NUMBER: SC466260 (Scotland)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

MACKAY MEDICAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

A D Mackay

V A Mackay

SECRETARY:

REGISTERED OFFICE:

The Alhambra Suite

82 Mitchell Street

Glasgow

G1 3NA

REGISTERED NUMBER:

SC466260 (Scotland)

ACCOUNTANTS:

Portlands

The Alhambra Suite

82 Mitchell Street

Glasgow

G1 3NA

FIXED ASSETS

Tangible assets

4

50,199

18,494

CURRENT ASSETS

Debtors

5

59,757

5,066

Cash at bank

170,622

196,351

230,379

201,417

CREDITORS

Amounts falling due within one year

6

(65,090

)

(27,341

)

NET CURRENT ASSETS

165,289

174,076

TOTAL ASSETS LESS CURRENT LIABILITIES

215,488

192,570

CREDITORS

Amounts falling due after more than one year

7

-

(15,187

)

NET ASSETS

215,488

177,383

CAPITAL AND RESERVES

Called up share capital

1,000

1,000

Retained earnings

214,488

176,383

215,488

177,383

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 September 2025 and were signed on its behalf by:

A D Mackay - Director

1.	STATUTORY INFORMATION

Mackay Medical Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

50% on reducing balance and 25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 January 2024

69,823

Additions

63,932

Disposals

(48,890

)

At 31 December 2024

84,865

DEPRECIATION

At 1 January 2024

51,329

Charge for year

17,560

Eliminated on disposal

(34,223

)

At 31 December 2024

34,666

NET BOOK VALUE

At 31 December 2024

50,199

At 31 December 2023

18,494

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

4,341

4,341

Other debtors

55,416

725

59,757

5,066

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Bank loans and overdrafts

-

10,597

Hire purchase contracts

53,170

-

Taxation and social security

6,100

13,924

Other creditors

5,820

2,820

65,090

27,341

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2024

2023

£

£

Other creditors

-

15,187